There have been recalls of other digoxin brands since this massive Digitek recall in the spring of 2008. As of May 13th, 2009 the most recent has been a recall on Caraco brand digoxin.A class 1 recall is being issued on all Digitek (digoxin) tablets, which may contain twice the approved level of digoxin.
This March 31 press release from Caraco, a generic pharmaceutical company, states that:
"All tablets of Caraco brand Digoxin, USP, 0.125 mg, and Digoxin, USP, 0.25 mg, distributed prior to March 31, 2009, which are not expired and are within the expiration date of September, 2011, are being voluntarily recalled to the consumer level. The tablets are being recalled because they may differ in size and therefore could have more or less of the active ingredient, digoxin."
Almost a year ago, in late April 2008, all digoxin pills manufactured by Actavis Totowa were recalled due to this so-called "double-dose" manufacturing problem. Those Digitek pills were distributed by Mylan Pharmaceuticals under the Bertek and UDL labels. The existence of double-strength pills pose a risk of digitalis toxicity, which can result in nausea, vomiting, low blood pressure, cardiac instability, bradycardia and even death.
No comments:
Post a Comment